ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Youngandnaive
|
1.0K |
452K |
0 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
1.0K
|
452K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Youngandnaive
|
1.0K |
452K |
5 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
1.0K
|
452K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Ys- J Swedish,B Burns,J Bell,P Krause,P Facchina
|
|
Youngandnaive
|
11 |
4.5K |
27 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
11
|
4.5K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Ys- J Swedish,B Burns,J Bell,P Krause,P Facchina
|
|
Youngandnaive
|
11 |
4.5K |
21 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
11
|
4.5K
|
21
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Youngandnaive
|
10K |
4.9M |
21 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
10K
|
4.9M
|
21
|
|
ASX - By Stock
|
BRN |
Re:
Ann: Change of Director's Interest Notice - Van Der Made
|
|
Youngandnaive
|
262 |
85K |
1 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
262
|
85K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze.co sold out???
|
|
Youngandnaive
|
55 |
18K |
6 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
55
|
18K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze.co sold out???
|
|
Youngandnaive
|
55 |
18K |
7 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
55
|
18K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Youngandnaive
|
18K |
7.1M |
4 |
03/08/21 |
03/08/21 |
ASX - By Stock
|
18K
|
7.1M
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Has a licensing deal been struck for VIRALEZE™ nasal spray
|
|
Youngandnaive
|
93 |
32K |
6 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
93
|
32K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze Sponsors Harlequins Rugby
|
|
Youngandnaive
|
28 |
8.8K |
2 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
28
|
8.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze Sponsors Harlequins Rugby
|
|
Youngandnaive
|
28 |
8.8K |
5 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
28
|
8.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze marketing
|
|
Youngandnaive
|
169 |
54K |
4 |
04/04/21 |
04/04/21 |
ASX - By Stock
|
169
|
54K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Youngandnaive
|
796 |
398K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
398K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Youngandnaive
|
796 |
398K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
398K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
Youngandnaive
|
445 |
197K |
1 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
445
|
197K
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
Youngandnaive
|
29K |
14M |
9 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
29K
|
14M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Youngandnaive
|
12K |
3.9M |
1 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
12K
|
3.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Warning! Alpha Exposure is on the case again
|
|
Youngandnaive
|
10 |
6.3K |
8 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
10
|
6.3K
|
8
|
|
ASX - By Stock
|
MSB |
Warning! Alpha Exposure is on the case again
|
|
Youngandnaive
|
10 |
6.3K |
7 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
10
|
6.3K
|
7
|
|
ASX - By Stock
|
BRN |
Re:
New BRN, neuromorphic media article
|
|
Youngandnaive
|
613 |
4.1M |
8 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
613
|
4.1M
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Youngandnaive
|
23K |
13M |
11 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Youngandnaive
|
23K |
13M |
11 |
03/04/20 |
03/04/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
trial time
|
|
Youngandnaive
|
35 |
15K |
17 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
35
|
15K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
trial time
|
|
Youngandnaive
|
35 |
15K |
16 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
35
|
15K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports supportive efficacy data from AIPAC study
|
|
Youngandnaive
|
116 |
55K |
1 |
25/03/20 |
25/03/20 |
ASX - By Stock
|
116
|
55K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Youngandnaive
|
443 |
202K |
1 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
443
|
202K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast owns the patents . The science is now proven .
|
|
Youngandnaive
|
47 |
23K |
7 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
47
|
23K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Youngandnaive
|
443 |
202K |
2 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
443
|
202K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease
|
|
Youngandnaive
|
443 |
202K |
1 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
443
|
202K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Recognition
|
|
Youngandnaive
|
14 |
12K |
4 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
14
|
12K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Youngandnaive
|
4.4K |
2.4M |
1 |
08/09/19 |
08/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Bacterial vaginosis solutions
|
|
Youngandnaive
|
32 |
11K |
8 |
13/07/19 |
13/07/19 |
ASX - By Stock
|
32
|
11K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Youngandnaive
|
4.4K |
2.4M |
1 |
22/06/19 |
22/06/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Competition/ experiment..prediction of MSB price @ close of business June 28 2019
|
|
Youngandnaive
|
135 |
55K |
2 |
10/04/19 |
10/04/19 |
ASX - By Stock
|
135
|
55K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Future Company Valuations in general & MSB
|
|
Youngandnaive
|
36 |
11K |
1 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
36
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial
|
|
Youngandnaive
|
61 |
21K |
7 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
61
|
21K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
This is amazing a medical breakthrough BD1 should skyrocket
|
|
Youngandnaive
|
2 |
1.3K |
0 |
11/01/18 |
11/01/18 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
Youngandnaive
|
629 |
257K |
0 |
27/12/17 |
27/12/17 |
ASX - By Stock
|
629
|
257K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ.....
|
|
Youngandnaive
|
42 |
13K |
5 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
42
|
13K
|
5
|
|
ASX - By Stock
|
SYT |
Re:
Ann: Trading Halt
|
|
Youngandnaive
|
357 |
91K |
6 |
05/12/17 |
05/12/17 |
ASX - By Stock
|
357
|
91K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
IMM- Good start on new Sticker !
|
|
Youngandnaive
|
54 |
17K |
0 |
01/12/17 |
01/12/17 |
ASX - By Stock
|
54
|
17K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
* article
|
|
Youngandnaive
|
5 |
3.3K |
8 |
26/11/17 |
26/11/17 |
ASX - By Stock
|
5
|
3.3K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
Brainchip Q & A
|
|
Youngandnaive
|
101 |
44K |
0 |
24/11/17 |
24/11/17 |
ASX - By Stock
|
101
|
44K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast has turned a corner
|
|
Youngandnaive
|
840 |
222K |
7 |
19/11/17 |
19/11/17 |
ASX - By Stock
|
840
|
222K
|
7
|
|
ASX - By Stock
|
NOR |
Re:
Ann: Trading Halt
|
|
Youngandnaive
|
108 |
36K |
0 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
108
|
36K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Phase 2 Trial Results Show Early and Durable Effects of Single Mesenchymal Precursor Cell
|
|
Youngandnaive
|
278 |
62K |
2 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
278
|
62K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: SITC 2017 Poster Presentation
|
|
Youngandnaive
|
50 |
24K |
7 |
10/11/17 |
10/11/17 |
ASX - By Stock
|
50
|
24K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
massive buy recommendation
|
|
Youngandnaive
|
333 |
127K |
12 |
10/10/17 |
10/10/17 |
ASX - By Stock
|
333
|
127K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
The Competitive Challenge
|
|
Youngandnaive
|
29 |
7.3K |
3 |
11/08/17 |
11/08/17 |
ASX - By Stock
|
29
|
7.3K
|
3
|
|